IMMX

Immix Biopharma, Inc. $7.68 as of 2026-10-30
Model view — historical tendencies for the days ahead, not a forecast
Next 1 day
+0.3%
Next 1 week
+2.7%
Next 1 month
+4.0%
Seasonality
Not enough history
20-year seasonality chart →
Mean reversion
Deeply oversold — RSI(2) at 5
RSI(2) under 15 is oversold (this name has historically bounced); over 85 is overbought. Its dip-buy edge in history is +0.32%/day.
Mean-reversion stats →
1-month breakdown — Market · β 1.57 +3.8% · Seasonal tilt (4y) +0.2%
$11M/day volume 83% volatility +106% 1-year -49% from ATH
52-week range · 39% of the way up · -49% from the high
$2.85$15.10

Earnings Full history →

Next report 2026-11-06 (Friday, after close, in 5 days) · EPS est. -0.19.

1-day std dev
3.3%
Finished up
53%
Biggest pop
+4.2%
Biggest drop
-8.7%

Standard deviation of the close-to-close move over the last 15 reports. History, not a forecast.

ReportedEst.Actual SurpriseGap Day 1Day 5
2026-08-07 miss -0.18 -0.18 -2.4% +0.4% +4.2% +16.7%
2026-05-07 beat -0.21 -0.18 +13.2% -1.8% +2.2% +4.2%
2026-03-25 miss -0.16 -0.28 -75.0% -8.8% -2.1% +0.3%
2025-11-07 miss -0.19 -0.24 -26.3% +3.5% +2.9% +28.3%
2025-08-08 miss -0.16 -0.22 -37.5% +0.0% -2.9% -3.8%
2025-05-08 beat -0.23 -0.15 +34.8% -2.1% -2.6% -4.0%
2025-03-25 beat -0.25 -0.15 +40.0% -0.3% +1.6% -11.5%
2024-11-12 miss -0.16 -0.24 -50.0% -1.7% -8.7% +5.8%
2024-08-12 beat -0.21 -0.15 +28.6% +0.0% +0.5% +17.3%
2024-05-09 beat -0.23 -0.22 +4.3% -5.5% +0.0% +13.3%
2024-03-29 miss -0.23 -0.24 -4.3% -2.1% +0.7% -2.7%
2023-11-13 -0.23 -0.23 — +0.2% +1.4% +5.3%
2023-08-11 miss -0.17 -0.24 -41.2% -1.1% +0.5% +8.2%
2023-05-12 miss -0.14 -0.18 -28.6% -1.4% -3.3% -17.8%
2023-03-27 miss -0.22 -0.27 -22.7% +3.2% -3.8% -6.5%

Not investment advice.